Trial Profile
Clinical Trials Insight: 700007760
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 13 Nov 2005
Price :
$35
*
At a glance
- Drugs Omacetaxine mepesuccinate (Primary)
- Indications Myelodysplastic syndromes
- Focus Therapeutic Use
- 13 Nov 2005 New trial record.